Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts

Area of Science:

• Developmental biology
• Craniofacial surgery
• Regenerative medicine

Background:

• Orofacial clefts present significant patient, family, and healthcare burdens.
• Current treatments involve lifelong surgeries and multidisciplinary care for functional and aesthetic restoration.
• Understanding molecular signaling in palate development is crucial for novel prenatal interventions.

Purpose of the Study:

• To review current surgical management of orofacial clefts.
• To explore advances in prenatal diagnostics and in utero surgical corrections.
• To emphasize molecular signaling pathways in palatogenesis for therapeutic development.

Main Methods:

• Review of surgical techniques for cleft repair.
• Analysis of prenatal diagnostic advancements (imaging, genomics).
• Examination of in utero surgical correction attempts.
• Overview of key molecular signaling pathways (Tgfβ, Shh, Wnt, Bmp, Fgf).

Main Results:

• Current standard of care involves extensive postnatal surgical interventions.
• Prenatal diagnostics and in utero surgeries show evolving potential.
• Key molecular mediators driving palatogenesis are identified.
• Pros and cons of in utero therapies for restoring molecular homeostasis are presented.

Conclusions:

• Developing preclinical molecular therapies is essential for early correction of orofacial clefts.
• Translation of these therapies into human trials could revolutionize treatment.
• A deeper understanding of signaling pathways is key to advancing prenatal interventions.